Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Pacira BioSciences, Inc. | 20,000 | reported | 07 Aug 2014 | tx 48+385,587−319,700 |
| OSCIENT PHARMACEUTICALS CORP | 14,141 | reported | 12 Jun 2008 | tx 25+10,500−265,919 |
| Xenon Pharmaceuticals Inc. | 1,593 | reported | 03 Jun 2026 | tx 69+226,588−115,369 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 01 Jun 2026 | EXERCISE | Xenon Pharmaceuticals Inc. | 2,645 | — | |
| 01 Jun 2026 | EXERCISE | Xenon Pharmaceuticals Inc. | 2,645 | 0.00 USD | deriv |
| 03 Jun 2026 | GRANT_AWARD | Xenon Pharmaceuticals Inc. | 10,507 | 0.00 USD | deriv |
| 03 Jun 2026 | GRANT_AWARD | Xenon Pharmaceuticals Inc. | 1,593 | 0.00 USD | deriv |
| 05 Jun 2025 | GRANT_AWARD | Xenon Pharmaceuticals Inc. | 17,012 | 0.00 USD | deriv |
| 05 Jun 2025 | GRANT_AWARD | Xenon Pharmaceuticals Inc. | 2,645 | 0.00 USD | deriv |
| 22 Nov 2024 | EXERCISE | Xenon Pharmaceuticals Inc. | 3,500 | 7.38 USD | |
| 22 Nov 2024 | TAX_WITHHOLDING | Xenon Pharmaceuticals Inc. | 649 | 39.80 USD | |
| 22 Nov 2024 | SALE | Xenon Pharmaceuticals Inc. | 2,040 | 41.05 USD | |
| 22 Nov 2024 | EXERCISE | Xenon Pharmaceuticals Inc. | 3,086 | 13.48 USD | |
| 22 Nov 2024 | TAX_WITHHOLDING | Xenon Pharmaceuticals Inc. | 1,046 | 39.80 USD | |
| 22 Nov 2024 | SALE | Xenon Pharmaceuticals Inc. | 2,851 | 41.11 USD | |
| 22 Nov 2024 | EXERCISE | Xenon Pharmaceuticals Inc. | 3,500 | 0.00 USD | deriv |
| 22 Nov 2024 | EXERCISE | Xenon Pharmaceuticals Inc. | 3,086 | 0.00 USD | deriv |
| 05 Jun 2024 | GRANT_AWARD | Xenon Pharmaceuticals Inc. | 15,542 | 0.00 USD | deriv |
| 13 Dec 2023 | SALE | Xenon Pharmaceuticals Inc. | 5,100 | 38.94 USD | |
| 13 Dec 2023 | SALE | Xenon Pharmaceuticals Inc. | 2,303 | 39.10 USD | |
| 13 Dec 2023 | EXERCISE | Xenon Pharmaceuticals Inc. | 5,144 | 9.00 USD | |
| 13 Dec 2023 | TAX_WITHHOLDING | Xenon Pharmaceuticals Inc. | 1,167 | 39.68 USD | |
| 13 Dec 2023 | SALE | Xenon Pharmaceuticals Inc. | 3,977 | 39.84 USD | |
| 13 Dec 2023 | TAX_WITHHOLDING | Xenon Pharmaceuticals Inc. | 577 | 39.68 USD | |
| 13 Dec 2023 | EXERCISE | Xenon Pharmaceuticals Inc. | 2,880 | 9.85 USD | |
| 13 Dec 2023 | SALE | Xenon Pharmaceuticals Inc. | 7,598 | 41.05 USD | |
| 13 Dec 2023 | TAX_WITHHOLDING | Xenon Pharmaceuticals Inc. | 1,278 | 39.68 USD | |
| 13 Dec 2023 | EXERCISE | Xenon Pharmaceuticals Inc. | 6,378 | 9.85 USD |
1 purchase reported after at least 12 months of silence — most recent on 17 Mar 2021.